(Q48336501)

10 February 2018

title

Loss of somatostatin-like immunoreactivity in the frontal cortex of Alzheimer patients carrying the apolipoprotein epsilon 4 allele. (English)

1 reference

10 February 2018

0 references

0 references

Grouselle D

1

1 reference

10 February 2018

Winsky-Sommerer R

2

1 reference

10 February 2018

David JP

3

1 reference

10 February 2018

Delacourte A

4

1 reference

10 February 2018

Dournaud P

5

1 reference

10 February 2018

Epelbaum J

6

1 reference

10 February 2018

language of work or name

English

0 references

publication date

1 October 1998

1 reference

10 February 2018

number of pages

4

1 reference

inferred from page(s)

published in

Neuroscience Letters

1 reference

10 February 2018

volume

255

1 reference

10 February 2018

issue

1

1 reference

10 February 2018

page(s)

21-24

1 reference

10 February 2018

Apolipoprotein epsilon 4 allele and disease progression in patients with late-onset Alzheimer's disease.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900698-3

7 January 2021

Evidence that the APOE locus influences rate of disease progression in late onset familial Alzheimer's Disease but is not causative

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900698-3

7 January 2021

AD2, a phosphorylation-dependent monoclonal antibody directed against tau proteins found in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900698-3

7 January 2021

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900698-3

7 January 2021

Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900698-3

7 January 2021

Decreased somatostatin immunoreactivity but not neuropeptide Y immunoreactivity in cerebral cortex in senile dementia of Alzheimer type.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900698-3

7 January 2021

A cortical neuropeptide with neuronal depressant and sleep-modulating properties

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900698-3

7 January 2021

Somatostatin messenger RNA-containing neurons in Alzheimer's disease: an in situ hybridization study in hippocampus, parahippocampal cortex and frontal cortex.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900698-3

7 January 2021

Differential correlation between neurochemical deficits, neuropathology, and cognitive status in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900698-3

7 January 2021

Identification and characterization of a novel human cortistatin-like peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900698-3

7 January 2021

Quantitative analysis of senile plaques in Alzheimer disease: observation of log-normal size distribution and molecular epidemiology of differences associated with apolipoprotein E genotype and trisomy 21 (Down syndrome).

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900698-3

7 January 2021

Apolipoprotein E4 allele and Alzheimer disease: examination of allelic association and effect on age at onset in both early- and late-onset cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900698-3

7 January 2021

Apolipoprotein E: cholesterol transport protein with expanding role in cell biology

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900698-3

7 January 2021

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900698-3

7 January 2021

High-molecular-weight forms of somatostatin are reduced in Alzheimer's disease and Down's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900698-3

7 January 2021

Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900698-3

7 January 2021

Apolipoprotein E polymorphism and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900698-3

7 January 2021

Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900698-3

7 January 2021

Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900698-3

7 January 2021

Chromatographic and Biological Properties of Immunoreactive Somatostatin in Hypothalamic and Extrahypothalamic Brain Regions of the Rat*

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900698-3

7 January 2021

Two-dimensional characterization of paired helical filament-tau from Alzheimer's disease: demonstration of an additional 74-kDa component and age-related biochemical modifications.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900698-3

7 January 2021

A severe loss of choline acetyltransferase in the frontal cortex of Alzheimer patients carrying apolipoprotein epsilon 4 allele

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900698-3

7 January 2021

Molecular forms of somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with senile dementia of the Alzheimer type.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900698-3

7 January 2021

Nicotinic receptors, muscarinic receptors and choline acetyltransferase activity in the temporal cortex of Alzheimer patients with differing apolipoprotein E genotypes.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900698-3

7 January 2021

Selective lesion of the cholinergic basal forebrain causes a loss of cortical neuropeptide Y and somatostatin neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900698-3

7 January 2021

10.1016/S0304-3940(98)00698-3

Identifiers

DOI

1 reference

10 February 2018

PubMed ID

9839717

1 reference

10 February 2018